Laura Grohs - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Laura Grohs

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Pathologie (Heidelberg, Germany)|June 24, 2026

[Genetic diagnostics]Laura Grohs, Felix Marbach, Stefan Aretz

Frontiers in Pharmacology|April 3, 2023

Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptorLaura Grohs, Linhan Cheng, Saskia Cönen, et al.

Frontiers in Pharmacology|June 19, 2023

Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptorLaura Grohs, Linhan Cheng, Saskia Cönen, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Pathologie (Heidelberg, Germany)|June 24, 2026

[Genetic diagnostics]Laura Grohs, Felix Marbach, Stefan Aretz

Frontiers in Pharmacology|April 3, 2023

Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptorLaura Grohs, Linhan Cheng, Saskia Cönen, et al.

Frontiers in Pharmacology|June 19, 2023

Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptorLaura Grohs, Linhan Cheng, Saskia Cönen, et al.

Pageof 1